- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 28, 2026 | 114.2M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 96.1M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 66.9M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $32M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $19M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $11M |
| Capex | Q1 2026 · Mar 31, 2026 | $26M |
| Capex | Q1 2026 · Mar 31, 2025 | $36M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$31M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$21M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $2.75B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $2.58B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $4M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $6M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $392M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $772M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.72B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.19B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.37B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.04B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.17B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.73B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $10.19B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.14B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.93 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.31 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.93 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.32 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $241M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $161M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$89M |
| Net Income | Q1 2026 · Mar 31, 2025 | $21M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$82M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $69M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $206M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $247M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.53B |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $982M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.73B |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.23B |